|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 01 Mar 2019
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 01 Mar 2019
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 01 Mar 2019
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 01 Mar 2019
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 01 Mar 2019
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 01 Mar 2019
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 01 Mar 2019
|
|
Related companies:
Genmab A/S |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 01 Mar 2019
|
|
Related companies:
Oasmia Pharmaceutical AB |
|
|
SHANGHAI, March 1, 2019 /PRNewswire/ -- Sanofi announced that Pius S. Hornstein, PhD, has been appointed the new General Manager China, China & Emerging Markets Global Business Unit (GBU) of Sanofi and Country Chair of Sanofi China, effective today. Based in Shanghai, he reports directly... Read more ›› |
|
By: PR Newswire Association LLC. - 01 Mar 2019
|
|
|
SHANGHAI, March 1, 2019 /PRNewswire/ -- Sanofi announced that Pius S. Hornstein, PhD, has been appointed the new General Manager China, China & Emerging Markets Global Business Unit (GBU) of Sanofi and Country Chair of Sanofi China, effective today. Based in Shanghai, he reports directly... Read more ›› |
|
By: PR Newswire Association LLC. - 01 Mar 2019
|
|
|
SHANGHAI, March 1, 2019 /PRNewswire/ -- Sanofi announced that Pius S. Hornstein, PhD, has been appointed the new General Manager China, China & Emerging Markets Global Business Unit (GBU) of Sanofi and Country Chair of Sanofi China, effective today. Based in Shanghai, he reports directly... Read more ›› |
|
By: PR Newswire Association LLC. - 01 Mar 2019
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 01 Mar 2019
|
|
Related companies:
Ascendis Pharma A/S |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 01 Mar 2019
|
|
Related companies:
Orphazyme A/S |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 28 Feb 2019
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 28 Feb 2019
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 28 Feb 2019
|
|
Related companies:
Xbrane Biopharma AB |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 28 Feb 2019
|
|
Related companies:
Zealand Pharma A/S |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 28 Feb 2019
|
|
Related companies:
PCI Biotech Holding ASA |
|
|
BRUSSELS, Feb. 28, 2019 /PRNewswire/ -- "We are confident for the future growth of UCB based on strong delivery in 2018, marking the fifth year of profitable growth in a row and a new blockbuster for UCB, Vimpat(®)," said Jean-Christophe Tellier, CEO UCB. "We are expecting Cimzia(®) to reach... Read more ›› |
|
By: PR Newswire Association LLC. - 28 Feb 2019
|
|
|
BRUSSELS, Feb. 28, 2019 /PRNewswire/ -- "We are confident for the future growth of UCB based on strong delivery in 2018, marking the fifth year of profitable growth in a row and a new blockbuster for UCB, Vimpat(®)," said Jean-Christophe Tellier, CEO UCB. "We are expecting Cimzia(®) to reach... Read more ›› |
|
By: PR Newswire Association LLC. - 28 Feb 2019
|
|
|
|
|
|
Biotechgate Global Database ›
